Skin ConditionNCT04733859
Using Red Djulis Products Can Improve Skin Conditions
A study testing red djulis drinks in people with Skin Condition, run by TCI Co., Ltd. at 1 site in Taiwan.
Trial summary
Hypothesis: Using red djulis products can improve skin conditions Read more about this study
- Who is it for?
- Ages 20 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Skin Condition
- What is being tested?
- red djulis drinks
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 30 participants
- Where
- 1 siteTaiwan
- Study dates
- 1 Oct 2017to 31 Oct 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Dry skin
- Rough skin
- Large pores
- Dark yellow complexion
- Sagging skin
Who cannot join
- Skin disorders
- Liver diseases
- Kidney diseases
- Allergy to cosmetics, drugs, or foods
- Pregnant and lactating women
- People who had any cosmetic procedures before 4 weeks of the study
Show all 9Show fewer
- Area of facial spot over 3 cm2
- Vegan
- People who took collagen supplements in the past 3 months.
Trial locations and contacts
1 site in 1 country.
Taiwan1 site
Research & Design Center, TCI CO., Ltd
Taipei, Neipu Township, 100225
About this study
Hypothesis: Using red djulis products can improve skin conditions
- Conditions
- Skin Condition
- Being tested
- placebo group, red djulis drinks
- Medical subject headings
- Skin Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
placebo groupDietary supplement
subjects drank 50 ml , 1 bottle a day for 8 week
red djulis drinksDietary supplement
subjects drank 50 ml , 1 bottle a day for 8 week
| Study group | Role | What they receive |
|---|---|---|
| placebo group | Placebo comparator | subjects drank 50 ml , 1 bottle a day for 8 week Receives: Dietary Supplement: placebo group |
| red djulis drinks | Experimental | subjects drank 50 ml , 1 bottle a day for 8 week Receives: Dietary Supplement: red djulis drinks |
What is being measured
The primary outcome is the main question the study is designed to answer.
skin moisture
using corneometer CM825 to examine skin moisture (The higher the value, the more water content, C.U., corneometer units ). subjects drank 50 ml after meal
Measured: up to 8 week
skin elasticity
using cutometer dual MPA580 to examine skin elasticity (The closer the R2 value is to 1, the better the elasticity and no unit)
Measured: up to 8 week
skin gloss
using probe system GL2000 \& MPA10 to examine skin gloss (The higher the value, the higher the gloss, no unit)
Measured: up to 8 week
skin spot
usig VISIA-CR to examine skin spot (The higher the value, the larger the pore area, mm2)
Measured: up to 8 week
skin wrinkle
using VISIOSCAN-VC20 to examine skin wrinkle (The higher the value, the more wrinkles, surface evaluation of wrinkles, SEW)
Measured: up to 8 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Feb 2021
- Study start1 Oct 2017
- Primary completion31 Jul 2018
- Study completion31 Oct 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Skin ConditionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- TCI Co., Ltd.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Chia-Hua Liang, Ph.D, Principal investigator, Chia Nan University of Pharmacy ＆ Science
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04733859
- Sponsor's protocol ID
- 20180905RED
- Status last verified
- Jan 2021
- First submitted
- 26 Jan 2021
- Last updated
- 2 Feb 2021
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Feb 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Using Red Djulis Products Can Improve Skin Conditions
- ClinicalTrials.gov ID
- NCT04733859
- Acronym / sponsor ID
- 20180905RED
- Conditions
- Skin Condition
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- TCI Co., Ltd.Industry (pharma, biotech, devices)
- Study start
- 1 Oct 2017 (actual)
- Primary completion
- 31 Jul 2018 (actual)
- Study completion
- 31 Oct 2018 (actual)
- First posted
- 2 Feb 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hypothesis: Using red djulis products can improve skin conditions
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| placebo group | Placebo comparator | Dietary Supplement: placebo groupsubjects drank 50 ml , 1 bottle a day for 8 week |
| red djulis drinks | Experimental | Dietary Supplement: red djulis drinkssubjects drank 50 ml , 1 bottle a day for 8 week |
Who may qualify
- Ages
- 20 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Dry skin
- Rough skin
- Large pores
- Dark yellow complexion
- Sagging skin
Key exclusion criteria (9 listed)
- Skin disorders
- Liver diseases
- Kidney diseases
- Allergy to cosmetics, drugs, or foods
- Pregnant and lactating women
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| placebo groupsubjects drank 50 ml , 1 bottle a day for 8 week | Dietary supplement | placebo group |
| red djulis drinkssubjects drank 50 ml , 1 bottle a day for 8 week | Dietary supplement | red djulis drinks |
Primary outcome
skin moisture
Time frame: up to 8 week
using corneometer CM825 to examine skin moisture (The higher the value, the more water content, C.U., corneometer units ). subjects drank 50 ml after meal
skin elasticity
Time frame: up to 8 week
using cutometer dual MPA580 to examine skin elasticity (The closer the R2 value is to 1, the better the elasticity and no unit)
skin gloss
Time frame: up to 8 week
using probe system GL2000 \& MPA10 to examine skin gloss (The higher the value, the higher the gloss, no unit)
skin spot
Time frame: up to 8 week
usig VISIA-CR to examine skin spot (The higher the value, the larger the pore area, mm2)
skin wrinkle
Time frame: up to 8 week
using VISIOSCAN-VC20 to examine skin wrinkle (The higher the value, the more wrinkles, surface evaluation of wrinkles, SEW)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Feb 2021.
Related trials for Skin Condition
Active, not recruiting
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
Bone Metastases, HER2-positive Breast Cancer
Not yet recruitingObservational study
The Impact of Rheumatoid Arthritis Treatments on the Modulation of Extracellular Vesicles and Other Biomarkers Involved in the Development of Lung Cancer
Rheumatoid Arthritis (RA), Lung Neoplasms
Recruiting
IBS Skin Patch Test Food Allergy Study
Irritable Bowel Syndrome
RecruitingPhase 4
A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
Psoriasis, Colitis, Ulcerative
RecruitingPhase 3
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Breast Neoplasms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Chia-Hua Liang, Ph.D principal investigator
Chia Nan University of Pharmacy ＆ Science
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing red djulis drinks in people with Skin Condition, run by TCI Co., Ltd. at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
skin moisture (time frame: up to 8 week). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2021.